SIGLEC-9 ECD FUSION MOLECULES AND METHODS OF USE THEREOF

The present disclosure is generally directed to Siglec-9 ECDs and Siglec-9 ECD fusion molecules, and methods of treatment using Siglec-9 ECDs and Siglec-9 ECD fusion molecules.

Saved in:
Bibliographic Details
Main Authors BANKOTI, Rashmi, LIANG, Spencer, NALLE, Samuel, SUN, Jeonghoon, LONG, Hua
Format Patent
LanguageEnglish
French
German
Published 14.09.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present disclosure is generally directed to Siglec-9 ECDs and Siglec-9 ECD fusion molecules, and methods of treatment using Siglec-9 ECDs and Siglec-9 ECD fusion molecules.
Bibliography:Application Number: EP20200816024